What is the average price target for CHAMPIONX CORP (CHX) stock?
9 analysts have analysed CHX and the average price target is 42.23 USD. This implies a price increase of 63.61% is expected in the next year compared to the current price of 25.81.
NASDAQ:CHX • US15872M1045
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHAMPIONX CORP (CHX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-05 | Stifel | Maintains | Buy -> Buy |
| 2024-11-14 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-15 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-08 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-04 | Barclays | Maintains | Overweight -> Overweight |
| 2024-03-27 | Citigroup | Maintains | Buy -> Buy |
| 2024-01-08 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-11-14 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-10-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-26 | Stifel | Maintains | Buy -> Buy |
| 2023-10-17 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2023-07-26 | Citigroup | Maintains | Buy -> Buy |
| 2023-07-14 | Capital One | Initiate | Overweight |
| 2023-06-28 | Citigroup | Reiterate | Buy -> Buy |
| 2023-04-05 | Citigroup | Maintains | Buy |
| 2022-11-02 | Goldman Sachs | Maintains | Neutral |
| 2022-11-01 | Citigroup | Maintains | Buy |
| 2022-10-06 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2022-08-25 | Benchmark | Initiate | Buy |
| 2022-07-15 | B of A Securities | Upgrade | Neutral -> Buy |
| 2022-07-13 | Goldman Sachs | Maintains | Neutral |
| 2022-05-02 | Barclays | Maintains | Overweight |
| 2022-04-11 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2022-03-11 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-02-22 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.806B 23.77% | 3.758B -1.25% | 3.634B -3.31% | 3.541B -2.56% | 3.555B 0.40% | 3.615B 1.69% | 4.099B 13.39% | 4.296B 4.81% | 5.317B 23.77% | |
| EBITDA YoY % growth | 616.4M 45.55% | 748.837M 21.49% | 763.025M 1.89% | 798.63M 4.67% | 838.11M 4.94% | 785.12M -6.32% | 781.74M -0.43% | 823.15M 5.30% | 1.169B 42.02% | |
| EBIT YoY % growth | 374.5M 101.13% | 512.901M 36.96% | 517.2M 0.84% | 541.11M 4.62% | 592.91M 9.57% | 567.68M -4.26% | 566.61M -0.19% | 599.94M 5.88% | 955.46M 59.26% | |
| Operating Margin | 9.84% | 13.65% | 14.23% | 15.28% | 16.68% | 15.70% | 13.82% | 13.97% | 17.97% | |
| EPS YoY % growth | 1.26 110.00% | 1.70 34.92% | 1.81 6.47% | 1.93 6.36% | 1.95 1.30% | 2.10 7.70% | 2.31 10.12% | 2.51 8.73% | 3.60 42.97% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.46 24.58% | 0.46 4.40% | 0.45 -9.75% | 0.43 -13.88% | 0.49 5.83% | 0.52 12.36% | 0.52 14.82% |
| Revenue Q2Q % growth | 888.47M -0.54% | 884.22M -2.46% | 877.52M -3.78% | 823.9M -4.69% | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 188.94M -20.83% | 189.86M -39.40% | 187.77M -51.57% | 183.82M -0.50% | 206.33M 9.20% | 213.55M 12.48% | 214.2M 14.08% |
| EBIT Q2Q % growth | 133.85M 12.59% | 132.32M 1.79% | 127.92M -9.85% | 122.59M -1.68% | N/A | N/A | N/A |
All data in USD
9 analysts have analysed CHX and the average price target is 42.23 USD. This implies a price increase of 63.61% is expected in the next year compared to the current price of 25.81.
CHAMPIONX CORP (CHX) will report earnings on 2025-10-21, after the market close.
The consensus EPS estimate for the next earnings of CHAMPIONX CORP (CHX) is 0.46 USD and the consensus revenue estimate is 888.47M USD.
The number of analysts covering CHAMPIONX CORP (CHX) is 9.